Kcl-Retard

Potassium Chloride, the active ingredient in Kcl-Retard, is an electrolyte supplement presented as an oral formulation for oral use. It treats hypokalemia and potassium deficiency in patients who need potassium replacement therapy.

GNH USA supplies Kcl-Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kcl‑Retard is used to correct low potassium levels and support electrolyte balance in several clinical situations.

- Hypokalemia: restores normal serum potassium concentrations in patients with documented potassium loss. - Potassium deficiency: provides essential potassium for individuals with dietary insufficiency or chronic losses. - Diuretic‑induced potassium loss: maintains potassium homeostasis during treatment with loop or thiazide diuretics.

Kcl‑Retard may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Abdominal discomfort: cramping or pain in the upper abdomen. - Diarrhoea or loose stools: increased bowel frequency. - Constipation: reduced stool frequency or hardness. - Taste disturbance: metallic or salty after‑taste.

Serious or Rare Side Effects: - Hyperkalaemia: dangerously high serum potassium that can affect heart rhythm. - Cardiac arrhythmia: irregular heartbeat potentially leading to syncope. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Severe gastrointestinal irritation: ulceration or bleeding. - Life‑threatening cardiac arrest: in extreme hyperkalaemia cases.

Before prescribing Kcl‑Retard, clinicians should consider several safety factors.

- Renal impairment: monitor serum potassium and adjust dose as needed. - Cardiac disease: obtain baseline ECG and watch for arrhythmias. - Concomitant potassium‑sparing agents: avoid additive hyperkalaemia risk. - Gastrointestinal obstruction: do not use if blockage is present. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Kcl‑Retard can interact with other medicines that affect potassium balance.

Major Interactions (Avoid): - ACE inhibitors or ARBs: increase risk of hyperkalaemia. - Potassium‑sparing diuretics (e.g., spironolactone): additive potassium elevation. - NSAIDs: may impair renal potassium excretion.

Moderate Interactions (Monitor Closely): - Digoxin: heightened risk of digoxin toxicity with elevated potassium. - Beta‑blockers: may mask symptoms of hyperkalaemia. - Loop or thiazide diuretics: require potassium monitoring to avoid over‑correction.